Almost Half of European and US Pharmaceuticals Companies Struggle to Use Data Insight

Home
| The European | 17 May 2021

Inability to generate and use insights undermines competitiveness at 48% of drug companies surveyed

Nearly half of pharmaceutical companies (48%) admit their competitiveness is suffering because they cannot extract or use insights from data they already have within their business. An equal percentage (48%) admit they do not use their own data for business decisions as well as they could.

The findings are from research among 300 senior decision-makers within the pharmaceutical industry in the UK, US, Germany, France, Spain and Sweden, conducted by Aspen Technology, a global leader in asset optimisation software.

The research also reveals how poor digital capabilities hit business performance. Almost half (49%) say their companies struggle to use data effectively to improve time to market.

“This should sound an alarm bell within the pharmaceutical industry,” said David Leitham, Senior Vice President and General Manager Pharma, AspenTech. “Leading organisations stand out for their ability to use data effectively across all aspects of drug manufacture. Data-driven organisations are faster to innovate and respond to opportunities or threats at speed.”

The research also found a widespread lack of predictive capabilities within the industry. Almost half (49%) of respondents say their companies are not good enough at predicting demand for a product and adjusting output to match it. And almost as many (48%) rate their organisation as either poor or ineffective at using data to predict and resolve supply shortages.

Companies that have a more advanced digital culture use data effectively across all aspects of drug manufacture. More than three-quarters (78%) of such “digital culture leaders” in the research describe themselves as effective at using data to predict product demand and to forecast and resolve supply shortages.

“Pharma manufacturers have traditionally been moving slowly and incrementally towards ‘Pharma 4.0’,” said Leitham. “For more than half of all organisations this needs to accelerate if they are to avoid falling further behind.”

Further information

www.aspentech.com

Sign Up

For the latest news

Download the App free today

Follow
your favourite
business magazine
while on the go.
Available on

Hard Copy and Digital

Magazine
Subscription

Get your
favourite magazine
delivered directly
to you

£49.95 4 issues

ISF

Report

Read
Information Security Forum’s
special report
exclusively here

Read report

Other Home Articles You May Like

Website Design Canterbury

Magazine

Hard Copy and Digital Subscription

Please complete the payment process in order to receive all 4 issues of The European Magazine digital edition or receive the hard copy directly to your door
As soon as payment is processed, the current digital edition will be emailed to you or dispatch to your postal address.

Annual Quarterly Subscription (4 Issues) Shipping Options